EE03804B1 - Karboanhüdraasi inhibiitorite kasutamine ravimi valmistamiseks, mis on ette nähtud kollatähni turseravimiseks - Google Patents

Karboanhüdraasi inhibiitorite kasutamine ravimi valmistamiseks, mis on ette nähtud kollatähni turseravimiseks

Info

Publication number
EE03804B1
EE03804B1 EE9800263A EE9800263A EE03804B1 EE 03804 B1 EE03804 B1 EE 03804B1 EE 9800263 A EE9800263 A EE 9800263A EE 9800263 A EE9800263 A EE 9800263A EE 03804 B1 EE03804 B1 EE 03804B1
Authority
EE
Estonia
Prior art keywords
carbonic anhydrase
medicament
manufacture
treatment
macular edema
Prior art date
Application number
EE9800263A
Other languages
English (en)
Other versions
EE9800263A (et
Inventor
Eric Sponsel William
Harris Alon
Original Assignee
Advanced Research & Technology Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9605642.9A external-priority patent/GB9605642D0/en
Application filed by Advanced Research & Technology Institute filed Critical Advanced Research & Technology Institute
Publication of EE9800263A publication Critical patent/EE9800263A/et
Publication of EE03804B1 publication Critical patent/EE03804B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433—Thidiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/541—Non-condensed thiazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Eye Examination Apparatus (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
EE9800263A 1996-02-26 1997-02-25 Karboanhüdraasi inhibiitorite kasutamine ravimi valmistamiseks, mis on ette nähtud kollatähni turseravimiseks EE03804B1 (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1225096P 1996-02-26 1996-02-26
GBGB9605642.9A GB9605642D0 (en) 1996-03-18 1996-03-18 Treatment of macular edema
PCT/US1997/002874 WO1997030704A2 (en) 1996-02-26 1997-02-25 Use of carbonic anhydrase inhibitors for treating macular edema

Publications (2)

Publication Number Publication Date
EE9800263A EE9800263A (et) 1999-08-16
EE03804B1 true EE03804B1 (et) 2002-08-15

Family

ID=26308946

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9800263A EE03804B1 (et) 1996-02-26 1997-02-25 Karboanhüdraasi inhibiitorite kasutamine ravimi valmistamiseks, mis on ette nähtud kollatähni turseravimiseks

Country Status (26)

Country Link
EP (1) EP0954305B9 (et)
JP (1) JP4392481B2 (et)
KR (1) KR100471586B1 (et)
CN (1) CN1225582A (et)
AT (1) ATE239468T1 (et)
AU (1) AU727565B2 (et)
BG (1) BG64525B1 (et)
BR (1) BR9707674A (et)
CA (1) CA2247063C (et)
CZ (1) CZ299509B6 (et)
DE (1) DE69721824T2 (et)
DK (1) DK0954305T3 (et)
EA (1) EA001681B1 (et)
EE (1) EE03804B1 (et)
ES (1) ES2199348T4 (et)
HU (1) HU227161B1 (et)
IL (1) IL125912A0 (et)
IS (1) IS2053B (et)
MX (1) MXPA98006961A (et)
NO (1) NO320043B1 (et)
NZ (1) NZ331843A (et)
PT (1) PT954305E (et)
SK (1) SK284371B6 (et)
TR (1) TR199801665T2 (et)
WO (1) WO1997030704A2 (et)
YU (1) YU49422B (et)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9716657D0 (en) 1997-08-07 1997-10-15 Zeneca Ltd Chemical compounds
GB9803226D0 (en) 1998-02-17 1998-04-08 Zeneca Ltd Chemical compounds
EP1058546A4 (en) * 1998-03-06 2004-07-28 Univ Texas COMPILATIONS AND METHODS FOR THE TREATMENT OF MACULA DISEASES
US5948801A (en) * 1998-03-09 1999-09-07 Alcon Laboratories, Inc. Treatment of retinal edema with brinzolamide
JP2002520287A (ja) * 1998-07-10 2002-07-09 ザ・ユニバーシティ・オブ・シドニー 黄斑変性における血管新生の予防的治療
GB9902459D0 (en) 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
GB9902452D0 (en) 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
GB9902461D0 (en) 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
GB9902455D0 (en) 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
GB9902453D0 (en) 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
GB0000625D0 (en) 2000-01-13 2000-03-01 Zeneca Ltd Chemical compounds
US20030100594A1 (en) * 2001-08-10 2003-05-29 Pharmacia Corporation Carbonic anhydrase inhibitor
US20100063035A1 (en) 2006-12-15 2010-03-11 Nicox S.A. Carbonic anhydrase inhibitors derivatives
AR084194A1 (es) * 2010-12-09 2013-04-24 Fovea Pharmaceuticals Derivados de arilsulfonamida para la prevencion o el tratamiento de trastornos oftalmologicos especificos
JP2020504711A (ja) 2016-12-21 2020-02-13 バイオセリックス， インコーポレイテッド タンパク質を標的とすることにおいて使用するための、チエノピロール誘導体、その組成物、方法、および使用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4797413A (en) * 1986-05-14 1989-01-10 Merck & Co., Inc. Thieno thiopyran sulfonamide derivatives, pharmaceutical compositions and use
GB2223166B (en) * 1988-09-29 1992-03-18 American Cyanamid Co Stable ophthalmic preparations containing methazolamide
US5153192A (en) * 1990-04-09 1992-10-06 Alcon Laboratories, Inc. Thiophene sulfonamides useful as carbonic anhydrase inhibitors

Also Published As

Publication number Publication date
DE69721824T2 (de) 2004-03-11
NO983906D0 (no) 1998-08-25
HUP9902054A3 (en) 2001-07-30
BR9707674A (pt) 2000-01-04
NO983906L (no) 1998-10-19
IS4829A (is) 1998-08-20
EP0954305B1 (en) 2003-05-07
EA001681B1 (ru) 2001-06-25
WO1997030704A2 (en) 1997-08-28
KR19990087242A (ko) 1999-12-15
DE69721824D1 (de) 2003-06-12
ES2199348T3 (es) 2004-02-16
CZ299509B6 (cs) 2008-08-20
IL125912A0 (en) 1999-04-11
TR199801665T2 (xx) 1998-12-21
NO320043B1 (no) 2005-10-17
HUP9902054A1 (hu) 2000-03-28
KR100471586B1 (ko) 2005-07-11
ATE239468T1 (de) 2003-05-15
MXPA98006961A (es) 2004-11-19
BG64525B1 (bg) 2005-06-30
CA2247063A1 (en) 1997-08-28
ES2199348T4 (es) 2010-10-19
BG102797A (en) 1999-09-30
EP0954305A2 (en) 1999-11-10
AU1972197A (en) 1997-09-10
JP2000506833A (ja) 2000-06-06
PT954305E (pt) 2003-09-30
NZ331843A (en) 2000-09-29
YU35398A (sh) 2001-12-26
WO1997030704A3 (en) 1997-09-25
EE9800263A (et) 1999-08-16
DK0954305T3 (da) 2003-08-25
EP0954305B9 (en) 2010-08-04
HU227161B1 (en) 2010-09-28
CZ269998A3 (cs) 2000-01-12
SK284371B6 (sk) 2005-02-04
YU49422B (sh) 2006-01-16
EA199800764A1 (ru) 1999-06-24
CA2247063C (en) 2004-01-06
AU727565B2 (en) 2000-12-14
SK115198A3 (en) 2000-01-18
JP4392481B2 (ja) 2010-01-06
CN1225582A (zh) 1999-08-11
IS2053B (is) 2005-10-14

Similar Documents

Publication Publication Date Title
EE03804B1 (et) Karboanhüdraasi inhibiitorite kasutamine ravimi valmistamiseks, mis on ette nähtud kollatähni turseravimiseks
EP1550456A3 (en) Use of botulinum toxin in the treatment of burn pain
WO2000040235A3 (en) Treatment of asthma with mek inhibitors
NZ515567A (en) Method for treating chronic pain using MEK inhibitors
ES2059121T3 (es) Uso de agentes sensibilizantes de insulina para tratar la hipertension.
MY117918A (en) Use of an h+, k+- atpase inhibitor in the treatment of nasal polyps
TR200101149T2 (tr) Dış retina bozukluklarının tedavisi.
YU42298A (sh) Upotreba olanzapina za pripremanje leka korisnog kod akutnog bola
DK0855916T3 (da) Farmaceutisk præparat indeholdende en Activin-stimulator
UA66757C2 (en) Ophthalmologic composition of carbonic anhydrase inhibitors, method for treating or preventing macular edema or age-related macular degeneration
AU2001280093A1 (en) Method for the prevention and treatment of retinopathy
NO984196L (no) FremgangsmÕte for behandling av stoffmisbruk
NO984198L (no) FremgangsmÕte for behandling av aggresjon
SE9602145D0 (sv) New improved formulation for treatment of thromboembolism
NZ514490A (en) Method and means for treating post-polio syndrome
NO984190L (no) FremgangsmÕte for behandling av insomnia
EA200000514A1 (ru) Способ лечения эректильной дисфункции
MX9703975A (es) Nueva formulacion antitrombotica, proceso para su fabricacion y uso de la misma.
UA51556A (uk) Спосіб лікування хворих на уросепсис
RU94033502A (ru) Способ лечения детей, больных вторичным панкреатитом

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20091231

KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20110225